With the continual advancement of technology in surgery, one would expect that robotic prostatectomy to be the gold standard of treatment for prostate cancer. However, Judd Moul, MD, explains the reasons why open surgery is still superior to robotic surgery.

Reference:

Bio for Judd Moul, MD

Faculty and Financial Disclosures:

Judd Moul, MD
Salary: Duke Private Diagnostic Clinic, Duke University
Royalty: Up-To-Date, Inc.
Consulting Fees: Ferring, Amgen, sanofi aventis, Baxter, Medivation
Fees for Non-CME Services: Ferring, Amgen, sanofi aventis, Janssen, Dendreon, Iris